This site is intended for healthcare professionals
News

CHMP recommends approval of Imbruvica + Rituxan for chronic lymphocytic leukaemia.- Janssen

Read time: 1 mins
Last updated:27th Jul 2020
Published:25th Jul 2020
Condition: CLL/SLL
Type: drug
Register free for full access to medthority.com